Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
<p dir="ltr">Cancer testis antigens (CTAs) form a large family of proteins with highly restricted expression that is limited to male germ cells in the testis and trophoblast cells in the placenta. They are often re-expressed in tumors as a result of differential DNA methylation of th...
Saved in:
| Main Author: | Adviti Naik (673163) (author) |
|---|---|
| Other Authors: | Joe Yeong (3760072) (author), Julie Decock (44558) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
by: Ghaneya Al-Khadairi (14153274)
Published: (2019) -
Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
by: A. Naik (7783220)
Published: (2023) -
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
by: Afsheen Raza (492657)
Published: (2022) -
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
by: Remy Thomas (702843)
Published: (2020) -
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
by: Adviti Naik (673163)
Published: (2021)